Retirement Systems of Alabama Sells 5,458 Shares of Colgate-Palmolive (NYSE:CL)

Retirement Systems of Alabama decreased its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.9% during the 4th quarter, HoldingsChannel reports. The fund owned 181,464 shares of the company’s stock after selling 5,458 shares during the period. Retirement Systems of Alabama’s holdings in Colgate-Palmolive were worth $14,464,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. &PARTNERS increased its holdings in shares of Colgate-Palmolive by 0.7% in the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after purchasing an additional 129 shares during the period. West Branch Capital LLC increased its holdings in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the period. First Foundation Advisors increased its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after purchasing an additional 136 shares during the period. Waldron Private Wealth LLC increased its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the period. Finally, Autumn Glory Partners LLC increased its holdings in shares of Colgate-Palmolive by 2.7% in the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after purchasing an additional 140 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at approximately $24,161,117.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. In the last three months, insiders have sold 159,048 shares of company stock valued at $13,336,846. 0.37% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Bank of America increased their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday. Barclays increased their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research note on Tuesday. Morgan Stanley increased their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Wells Fargo & Company increased their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday. Finally, The Goldman Sachs Group started coverage on Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Read Our Latest Analysis on CL

Colgate-Palmolive Stock Down 0.0 %

NYSE CL opened at $91.90 on Thursday. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.28. The stock has a market capitalization of $75.40 billion, a PE ratio of 29.08, a PEG ratio of 3.37 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $92.54. The business’s 50-day moving average is $88.08 and its 200 day moving average is $81.99.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm earned $0.73 earnings per share. Sell-side analysts forecast that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.18%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.